Libya vs Peru: Cause of death, by non-communicable diseases, ages 5-14, male
Libya
41.6%
in 2021
Peru
40.7%
in 2021
Libya rank
70th
Peru rank
73rd
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Libya
- Peru
How they compare
Libya currently reports 41.6% against 40.7% in Peru, a difference of 0.9%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Libya ahead.
Libya ranks 70th and Peru ranks 73rd of 185 countries.
Across the 3 decades both report, Libya averaged higher in 1 and Peru in 2.
Head to head by decade
| Decade | Libya | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40.2% | 33.6% | 6.6% | Libya |
| 2010s | 29.3% | 41.3% | 11.9% | Peru |
| 2020s | 36.2% | 42.4% | 6.3% | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Libya or Peru?
- Libya, at 41.6% against 40.7% in Peru as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Libya and Peru?
- 0.9%, with Libya ahead.
- How many years of comparable data are there for Libya and Peru?
- 6 years are reported by both, from 2000 to 2021.
- How do Libya and Peru rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Libya ranks 70th and Peru ranks 73rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.